Skip to content

Study · Animal study (in vivo) · cat · 1980

2 results

Pancreatic secretion and cyclic AMP in pancreatic tissue after intravenous infusion of secretin and vasoactive intestinal peptide in cats.

Mikoś E, Mitis-Musioł M, Radecki T, Konturek S

Acta physiologica Polonica1 Jan 1980

PMID6246717 (opens in a new tab)PepBankPUB-06246717
Publisher pageAsk about this study
Jump to 2 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study2

2 results from studies that gave the peptide. No result from this study comes from people.

  1. 01AnimalAnimal study (in vivo)Efficacy outcome

    In cats, intravenous VIP increased pancreatic bicarbonate secretion in a dose-dependent manner.

    In plain wordsIn cats, VIP given into a vein increased pancreatic bicarbonate secretion, and higher doses gave more.

    Peptide
    Vasoactive intestinal peptide (VIP, aviptadil)
    Outcome
    IncreasePancreatic bicarbonate secretion
    Study

    catn: not reported in source

    anesthetised cats, pancreatic secretion and tissue homogenates
    Outcome group
    Gastrointestinal protection · Gastrointestinal
    Studied dose
    Dose not stated · intravenousAs given in this study (cat).

    Source sentences

    Summary
    secretin and vasoactive intestinal peptide increased dose-dependently pancreatic bicarbonate secretion and cyclic AMP content in pancreatic tissue homogenates in cats.
    1 context sentence
    Title · context
    Pancreatic secretion and cyclic AMP in pancreatic tissue after intravenous infusion of secretin and vasoactive intestinal peptide in cats.
  2. 02AnimalAnimal study (in vivo)Mechanism

    In cats, intravenous VIP increased cyclic AMP content in pancreatic tissue homogenates in a dose-dependent manner.

    In plain wordsIn cats, VIP given into a vein raised cyclic AMP levels in pancreatic tissue, and higher doses gave more.

    Peptide
    Vasoactive intestinal peptide (VIP, aviptadil)
    Outcome
    IncreaseCyclic AMP content in pancreatic tissue
    Study

    catn: not reported in source

    anesthetised cats, pancreatic secretion and tissue homogenates
    Outcome group
    Receptor activity and mechanism · Gastrointestinal
    Studied dose
    Dose not stated · intravenousAs given in this study (cat).

    Source sentences

    Summary
    secretin and vasoactive intestinal peptide increased dose-dependently pancreatic bicarbonate secretion and cyclic AMP content in pancreatic tissue homogenates in cats.
    1 context sentence
    Title · context
    Pancreatic secretion and cyclic AMP in pancreatic tissue after intravenous infusion of secretin and vasoactive intestinal peptide in cats.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    12 Oct 2026, 12:58 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 12:41 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.